It's that time of year again: 2025's Bio-IT World Conference & Expo (#BioITExpo / #BioIT2025) in #Boston.
I and others from the @RCHSolutions team will be at the show and exhibiting (Booth 207). Also co-hosting a Happy Hour with @awscloud. Let me know if you'll be there.
I'm excited to be returning to BIo-IT World / #BioIT21 in person, last year's event being virtual for obvious reasons. 20-Sep - 22-Sep and a new location this year -- the Boston Sheraton. Hoping that attendees will stop-by to visit @RCHSolutions at booth #116.
Check out my latest article: IBM Announced the End of CentOS: What This Means for the Future of Linux-Based Life Sciences Compute https://t.co/0DnMAVgZN6 via @LinkedIn
A nice read! But extending its assertions suggests that [in]efficiencies of scripting languages inflate run costs in the Public Cloud (not a revolutionary perspective re: scripting vs compiled languages ... just some affirmation).
https://t.co/RwNUmGrkWg
Taking an informal survey, looking for feedback from #HPC types ... anyone else more than a bit miff’d that @awscloud is removing #SGE support from its Parallel Cluster offering?
Following a "wash, rinse, repeat" formula is how many organizations source or implement their outsourced or “tactical” support. There is a better solution out there—it’s called a Bio-IT Thought Partner.
https://t.co/sXHZANYUAW
"By combining our scientific expertise, technologies and capabilities, we believe that we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19," GSK CEO Emma Walmsley said.
https://t.co/iWZX2zwglj